Physician Capital, Inc.

At Physician Capital we specialize in creating revenue-driven solutions that empower private practices and physician-owned hospitals (POHs) to thrive in a competitive healthcare landscape. 

Our mission is to strengthen the financial health of these organizations by eliminating unnecessary expenses and maximizing revenue opportunities.

Co-Founder

Physician-Led Healthcare for America (PHA)

As a board member of Physician-Led Healthcare of America (PHA) and a frequent advocate in Washington, D.C., Dutch works tirelessly to champion legislation that promotes transparency, competition, and autonomy in healthcare. His monthly engagements in critical reform discussions ensure that private practices and physician-owned hospitals have a powerful voice in shaping their future.

Board Member

Bliksem Innovations ⚡️

Bliksem Innovations: 
Empowering Collaboration and Efficiency

Bliksem Innovations helps organizations reduce costs and create value through collaboration. We enable groups like universities, churches, energy companies, and independent medical practices to form shared entities for services like payroll, benefits, and insurance—benefiting their networks while maintaining autonomy.

Founder

PhyCap Fund

Advisor

Nomi Health

I am the founder of Sano Surgery and Everyone Health. We were acquired by Nomi Health July 2022.

Everyone Health

Direct Healthcare company serving self-funded and self-insured employers.

Co-Founder & Chief Executive Officer

Sano Surgery

Founder & Managing Partner

United States Marine Corps

25-31 Marine


Entrepreneur | Healthcare Advocate | Innovator

I’m an entrepreneur on a mission to make healthcare affordable and accessible for everyone, everywhere.

I lead Physician Capital, where we empower private practice doctors and physician-owned hospitals to reduce expenses and grow their businesses.

I’m also the co-founder of PhyCap Fund, a venture capital fund built by physicians, for the healthcare ecosystem. We invest in healthcare startups with real-world potential by leveraging our investor network of industry experts. 

Let’s connect to explore how we can transform healthcare together.


Why do nonprofit health systems hold billion-dollar investment portfolios while nurses work doubles and patients wait months for care?

If they are charities, why the tax exemptions?
If they are safety nets, why the debt collectors?
If they are mission-driven, why the executive bonuses?

The numbers don’t match the narrative.

Nonprofit in status.
For-profit in behavior.
Anti-competitive in practice.

Dutch Rojas

Coopetition is the new playbook for American business.

Every functional industry has three markets. 
Healthcare has zero. 

Patients can’t shop, employers can’t compare, 
and investors can’t discipline inefficiency. 

That’s why premiums never fall. 
Roll it....

𝐍𝐨𝐧𝐩𝐫𝐨𝐟𝐢𝐭 𝐡𝐞𝐚𝐥𝐭𝐡 𝐬𝐲𝐬𝐭𝐞𝐦𝐬 𝐡𝐚𝐯𝐞 𝐬𝐩𝐞𝐧𝐭 𝐭𝐡𝐞 𝐥𝐚𝐬𝐭 𝐭𝐰𝐞𝐧𝐭𝐲 𝐲𝐞𝐚𝐫𝐬 𝐜𝐨𝐧𝐯𝐢𝐧𝐜𝐢𝐧𝐠 𝐩𝐡𝐲𝐬𝐢𝐜𝐢𝐚𝐧𝐬 𝐭𝐡𝐚𝐭 𝐢𝐧𝐬𝐮𝐫𝐞𝐫𝐬 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐞𝐧𝐞𝐦𝐲. 

However, 
Only one group sets the prices that drive premiums, deductibles, and medical debt, and it is not the insurers.

Nonprofit health systems set the “chargemaster” rates. 

Nonprofit health systems bill 3–10x more than independent physicians for the same CPT code.

Nonprofit health systems demand facility fees for care that used to be outpatient and affordable.

Nonprofit health systems buy up practices to eliminate competition, then raise prices.

And then...

They pay executives millions
They accumulate real estate empires tax-free
They lobby to restrict physicians from owning their work
They hide behind the word “nonprofit” like a shield

If insurers disappeared tomorrow, prices would still be unaffordable — because the price setters would still be in charge.

Physicians: has your experience been that nonprofit health systems make care more affordable, or less?

Comment with one word:

Cheaper
or
Costlier

I’m genuinely curious whether anyone believes the nonprofit narrative is still real.

A physician lawsuit is directly challenging the legality of certificate-of-need (CON) laws, which require providers to get state approval before building new facilities or offering new services.

This hurts incumbent health systems who are protected from competition, and helps independent physicians and patients who would benefit from more choice and lower prices.

CON laws are the definition of a government-granted monopoly. They’re a relic of the past that stifle innovation and keep prices high. It’s time to let the market work. You don’t need permission to compete.

Open article: Eye surgeon, DHHS clash over CON law’s future in North Carolina by carolinajournal.com

Eye surgeon, DHHS clash over CON law’s future in North Carolina

Tennessee’s is the 44th worst state for affordable premiums. 

The bastion of free enterprise they say, while screwing over families. 

And I’d blame it on all the Hollywood people that moved to Franklin, but it wasn’t them. 

Tennessee sells a very specific story.

Low taxes.
Light regulation.
Business-friendly.

A state where government “gets out of the way” so entrepreneurs can build.

That branding isn’t subtle, it’s central to Tennessee’s identity. 

Legislators campaign on it. 
Chambers of commerce advertise it. 
Corporate recruiters evangelize it.

But the moment you step into healthcare, 
the story collapses.

The “open-for-business” state suddenly behaves like a command-and-control economy where innovation is regulated, competition is restricted, and powerful incumbents enjoy government protection that no other industry would ever receive.

In healthcare, 
Tennessee is not conservative. 
It is 100% communist. 

And it’s destroying Tennessee families in ways its politicians refuse to acknowledge.

Healthcare is the defining issue of the midterms. 

It is not immigration, 
not inflation, 
not foreign policy.

No household budget has risen faster than health insurance.

No industry has consolidated more rapidly (Thank you @CMSgov)

No sector hides prices more aggressively.
(Thank you State Governors)

The core problem:

The US subsidizes monopoly behavior and outlaw competition.

I have met a handful of US lawmakers  that articulate a policy agenda around transparency, site-neutral payments, 340B reform, and CON repeal. 

The rest? 
Lost in the sauce or intentionally naive.

Healthcare will decide this election.
Everything else is commentary.

“Give all power to the many, they will oppress the few.
Give all power to the few, they will oppress the many.” — Alexander Hamilton

This is the story of American healthcare in one sentence.

When CMS, state regulators, and giant health systems hold all the power, the results are predictable: prices are hidden, competition is illegal, physicians can’t open facilities without permission from their competitors, consolidation replaces choice, and premiums climb while outcomes don’t.

Certificate of Need (CON) laws are a perfect example. They don’t protect patients, they protect monopolies.

Price opacity isn’t an accident, it’s a business model. And consolidation isn’t efficiency, it’s control.

If America wants lower premiums, better care, and real access, we don’t need more regulatory centralization. 

America needs the opposite: price transparency, open competition, the end of CON, and a healthcare system where physicians and patients, not CMS and monopolies, decide what care looks like.

Power works best when it’s closer to the people who actually use it.

That’s how you restore affordability. 
That’s how you regain freedom.

Why are your premiums high?

Want to understand how the U.S. medical device industry really works? 

Don’t follow the technology. 

Follow the reimbursements.

This isn’t a free market. 

It’s a tightly controlled growth machine built on the Centers for Medicare and Medicaid (CMS) payment policy and protected by the American Hospital Association.

Device companies scale by riding procedure volume and procedure volume is manufactured by how CMS pays. 

Raise payment for joints? 
Implant sales spike. 

Green light electrophysiology? 
EP labs explode. 

Offer add-ons for robotics? Hospitals rush to buy da Vinci machines they can barely operate.

Health Systems, with the American Hospital Assholes (AHA) as their PR and legal shield, use site-of-service markups and facility fees to justify outrageous pricing. 

That margin? 
It buys the devices. 
It funds the expansion. 
It locks in procurement deals. 
It feeds consolidation.

This is excellence in strategy. 
Large systems mean predictable volumes and long-term tech loyalty. 
The device sector loves it.

That’s why med device lobbyists sing in harmony with CMS and the AHA, not out of shared values, but shared incentives.

So what threatens this cozy triad?

Independent docs. 
Site-neutral payments. 
Price transparency. 

In other words: competition.

That’s the battle line. 
Don’t mistake opposition to reform as a policy debate. 

It’s just margin defense.

Why are health insurance premiums sky-high in Massachusetts?

Harvard knows consolidation raises prices.

MIT knows competition lowers them.

Senator Warren built a career yelling about monopolies.

So why does the great state of Massachusetts  write laws that forbid competition and steer patients into the highest cost settings?

Massachusetts banned new ambulatory surgery centers for 10 straight years.

Not limited.
Not restricted.
Banned.
2008–2017.

And the state still wonders why it has only 8 ASCs per million people… less than half the national average.

A decade-long ban + competitor veto power = one outcome:
Massachusetts families now pay $6,000 more per year in premiums.

This is what regulatory capture looks like.

Watch this....

taplio

Dutch Rojas's Linkedin Analytics

Dutch Rojas

Performance ScoreDutch Rojas's LinkedIn Performance

Dutch Rojas's Best Posts (last 30 days)

Ready to grow your LinkedIn presence?

taplio

.css-6ytdur{background-image:linear-gradient(284deg, rgba(39, 43, 72, 1) 0%, rgba(33, 47, 183, 1) 100%);color:transparent;-webkit-background-clip:text;background-clip:text;}Dutch Rojas's Linkedin Analytics

Dutch Rojas

Performance Score.css-goub6s{font-size:var(--chakra-fontSizes-md);font-weight:500;color:var(--chakra-colors-gray-600);display:block;margin-top:var(--chakra-space-1);}Dutch Rojas's LinkedIn Performance

Dutch Rojas's Best Posts .css-1emoo84{font-size:var(--chakra-fontSizes-md);font-weight:400;color:var(--chakra-colors-gray-600);}(last 30 days)

Ready to grow your LinkedIn presence?

Dutch Rojas's Linkedin Analytics

Performance ScoreDutch Rojas's LinkedIn Performance

Dutch Rojas's Best Posts (last 30 days)